Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Preferred Shares (2019 - 2023)

ENDRA Life Sciences has reported Preferred Shares over the past 3 years, most recently at $1.0 for Q4 2021.

  • Quarterly Preferred Shares changed 0.0% to $1.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $1.0 through Dec 2021, changed 0.0% year-over-year, with the annual reading at $1.0 for FY2021, 0.0% changed from the prior year.
  • Preferred Shares was $1.0 for Q4 2021 at ENDRA Life Sciences, roughly flat from $1.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $1.0 in Q4 2019 and troughed at $1.0 in Q4 2019.
  • The 3-year median for Preferred Shares is $1.0 (2019), against an average of $1.0.
  • The largest YoY upside for Preferred Shares was 0.0% in 2020 against a maximum downside of 0.0% in 2020.
  • A 3-year view of Preferred Shares shows it stood at $1.0 in 2019, then changed by 0.0% to $1.0 in 2020, then changed by 0.0% to $1.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Preferred Shares are $1.0 (Q4 2021), $1.0 (Q3 2021), and $1.0 (Q1 2021).